Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
JAMA Ophthalmology
|
June 16, 2022
Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial
Margaret A Chang, Audrey Kapre, Derrick Kaufman, et al.
Ophthalmology and Therapy
|
June 27, 2022
Pharmacokinetics of the Port Delivery System with Ranibizumab in the Ladder Phase 2 Trial for Neovascular Age-Related Macular Degeneration
Charles C Wykoff, Peter A Campochiaro, Dante J Pieramici, et al.
Translational Vision Science & Technology
|
April 7, 2025
Structural Updates to the Implant and Refill Needle of the Port Delivery Platform
Dante J Pieramici, Peter A Campochiaro, Margaret Chang, et al.
Ophthalmology. Retina
|
November 20, 2020
End-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Arshad M Khanani, David Callanan, Richard Dreyer, et al.
Ophthalmology. Retina
|
August 29, 2024
Interim Results of the Phase III Portal Extension Trial of the Port Delivery System with Ranibizumab in Neovascular Age-Related Macular Degeneration
Peter A Campochiaro, David Eichenbaum, Margaret A Chang, et al.
Survey of Ophthalmology
|
February 1, 2019
Microperimetry for geographic atrophy secondary to age-related macular degeneration
Karl G Csaky, Praveen J Patel, Yasir J Sepah, et al.
Ophthalmology. Retina
|
May 19, 2022
Management of Key Ocular Adverse Events in Patients Implanted with the Port Delivery System with Ranibizumab
Carl C Awh, Giulio Barteselli, Sneha Makadia, et al.
JAMA Ophthalmology
|
March 6, 2025
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial
Arshad M Khanani, Peter A Campochiaro, Jordan M Graff, et al.
American Journal of Ophthalmology
|
July 15, 2023
Exudation in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System or Monthly Injections
Anam Akhlaq, David Williams, W Lloyd Clark, et al.
Ophthalmology
|
March 4, 2023
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results
Carl Regillo, Brian Berger, Logan Brooks, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
JAMA Ophthalmology
|
June 16, 2022
Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial
Margaret A Chang, Audrey Kapre, Derrick Kaufman, et al.
Ophthalmology and Therapy
|
June 27, 2022
Pharmacokinetics of the Port Delivery System with Ranibizumab in the Ladder Phase 2 Trial for Neovascular Age-Related Macular Degeneration
Charles C Wykoff, Peter A Campochiaro, Dante J Pieramici, et al.
Translational Vision Science & Technology
|
April 7, 2025
Structural Updates to the Implant and Refill Needle of the Port Delivery Platform
Dante J Pieramici, Peter A Campochiaro, Margaret Chang, et al.
Ophthalmology. Retina
|
November 20, 2020
End-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Arshad M Khanani, David Callanan, Richard Dreyer, et al.
Ophthalmology. Retina
|
August 29, 2024
Interim Results of the Phase III Portal Extension Trial of the Port Delivery System with Ranibizumab in Neovascular Age-Related Macular Degeneration
Peter A Campochiaro, David Eichenbaum, Margaret A Chang, et al.
Survey of Ophthalmology
|
February 1, 2019
Microperimetry for geographic atrophy secondary to age-related macular degeneration
Karl G Csaky, Praveen J Patel, Yasir J Sepah, et al.
Ophthalmology. Retina
|
May 19, 2022
Management of Key Ocular Adverse Events in Patients Implanted with the Port Delivery System with Ranibizumab
Carl C Awh, Giulio Barteselli, Sneha Makadia, et al.
JAMA Ophthalmology
|
March 6, 2025
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial
Arshad M Khanani, Peter A Campochiaro, Jordan M Graff, et al.
American Journal of Ophthalmology
|
July 15, 2023
Exudation in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System or Monthly Injections
Anam Akhlaq, David Williams, W Lloyd Clark, et al.
Ophthalmology
|
March 4, 2023
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results
Carl Regillo, Brian Berger, Logan Brooks, et al.
Page
of 4